Get started
VIMTA LABS LTDVIMTA LABS LTDVIMTA LABS LTD

VIMTA LABS LTD

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals

VIMTALABS trade ideas

Vimta Labs trying to be victorious.Vimta Labs Ltd. engages in the provision of contract research and testing. It services include cGMP laboratory services; analytical food and water; preclinical research; clinical research; biopharma; environmental assessments; and clinical reference lab. Vimta Labs Ltd. CMP is 558.20. The positive aspects of the company are Company with Low Debt, Company with Zero Promoter Pledge, Mutual Funds Increased Shareholding in Past Month and Good Aggregate Candlestick Strength. The Negative aspects of the company are High Valuation (P.E. = 30.2), Declining Net Cash Flow and Inefficient use of assets to generate profits. Entry can be taken after closing above 569 Targets in the stock will be 599, 617 and 643. The long-term target in the stock will be 667 and 702. Stop loss in the stock should be maintained at Closing below 517 or 503 depending upon your risk taking ability. Disclaimer: The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:VIMTALABSLong
by Happy_Candles_Investment
Darvas Box Strategy - Breakout StockDisclaimer: I am Not SEBI Registered adviser, please take advise from your financial adviser before investing in any stocks. Idea here shared is for education purpose only. Stock has given break out. Buy above high. Keep this stock in watch list. Buy above the High and do not forget to keep stop loss, best suitable for swing trading. Target and Stop loss Shown on Chart. As Stop loss is Big, Risk to Reward Ratio/ Target Ratio 1:1. Be Discipline, because discipline is the key to Success in Stock Market. Trade what you See Not what you Think.
NSE:VIMTALABS
by AnsariTV
#vimtalabs #ipcalab #lauruslabs #lalpathlab #guficbio #alkem#VIMTALABS NSE: VIMTALABS CMP: 461 TP: 560 SL: 410 TF: <6m RR > 2 times Return > 22% THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising Prices. Flag pattern breakout. Pennant Pattern Breakout with Bullish Candle. Retest Successful. Higher Highs & Higher Lows. Broken above RESISTANCE levels Trading at SUPPORT levels Earnings are strong. Bullish Wedge Breakout Risk Return Ratio is healthy. And Rising from Double Bottom Pattern to Flag Pattern forming. If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations. With 💚 from Rachit Sethia
NSE:VIMTALABSLong
by Rachit_Sethia
pe i just 19 while industry pe is 97. available at cheapVimta Labs is India’s leading contract research and testing organization. Established in 1984, Vimta has an envious track record of serving several market leaders across the globe. Vimta supports regulatory authorities in mandatory certification of food and agri products exported from India. Vimta assists the food industry commissions for nutritional labelling, food safety evaluations, trace analysis and shelf life studies. Vimta has a team of 684 professionals comprising 446 scientists in various disciplines such as chemistry, pharma, medicine, microbiology, molecular biology and informatics. The team is slated to double in next three years. Vimta is a multi-site organization with more than 300,000 sqft world class laboratory facilities. The technologies deployed at Vimta are current and leading edge, duly validated. Vimta has over 12 years of experience in providing preclinical services to Pharma companies world-wide accordance with the guidelines prescribed by international agencies. Vimta has a state-of-art building of Class 10,000 Pre-clinical facility with a total built up area of 33,000 sq.ft. with 32 rodent experimental rooms, 5 procedure rooms, separate quarantine facility and distinct non-rodent facility with 48 SS kennels with a comfortable perch, liberal exercise area. It provides services in pharmacology, toxicology and DMPK areas. The toxicology services include but not limited to in-vivo and in-vitro genotoxicity, acute to chronic toxicity, carcinogenicity, reproductive toxicity studies, safety pharmacology, and immunotoxicology. Pharmacology services are available in various therapeutics areas such as pain & inflammation, metabolic disorders, respiratory, CNS, and xenograft & allograft models for oncology. In addition to the regulatory studies we use tailor-made in vitro and in vivo ADME techniques to help profile your drug candidate in both rodent and non-rodent animals models. Services offered by the company: Advanced Molecular Biology Food and Agriculture Drugs & Pharma Water Environmental Assessments Clinical Research Clinical Reference Lab Services Preclinical Research Genomics Online Ordering
NSE:VIMTALABSLong
by Tradernawab
1
Breakout above multiple topsThis is a weekly chart of Vimta labs. This particular Breakout is called as breakout above multiple tops . If you see this chart, the stock has taken resistance around 343-344 around 3 times in the past. Now the stock has broken its previous resistance and its all time high simultaneously. This types of breakouts had given a lot of returns in the past. Usually it is observed that the stock doubles in 2 years. Please wait until tomorrow (Friday) so that we can get a confirmation. For Investors this is a great opportunity. Keep looking for these breakouts.
NSE:VIMTALABS
by AbNamjoshi
Buy Vimta lab - Double Bonanza offer! Only for limited time!My dear Investors, This is my first recommendation to buy Vimta Labs. CMP is 326.8. The stock has touched its all time high. This is the best time to buy this stock as henceforth it will be travelling under 'clear blue sky'. Indeed, there is no upper limit for this stock . On weekly charts, however, it is going to give breakout too so its a double bonanza offer . As per Fibonacci, Short term targets would be 362, 401, 440 and 465. On the other hand, long term targets would be 495, 767, 1039 and 1207. View - Medium to Long term. Time - 1 to 2 years.
NSE:VIMTALABSLong
by AbNamjoshi
2
VIMTALABS - Bullish pattern CMP 252 Long suggested at CMP (245 above) Stop 229 Target - Open Logic: Technicals : Stock has been steadily in uptrend as evident from MAs and RS / RSI Stock has made a series of correction to the extent of 25% / 22% and 17%, leading to contraction in pull backs. Stock has made a breakout post the pullback series with volume around 3x of pullback vols.(Note: volume masked in #VCP 29W 25/17 3T pattern Fundamentals : Last 4 quarters EPS growth YoY : 113%,108%,110%,508% Last 4 quarters Sales growth YoY: 15%, 22%, 32%, 40% D/E : 0.3 (Note : Promoter holding is only 37% )
NSE:VIMTALABSLong
by scorpiomanoj